Why Tandem Diabetes Care Stock Thrashed the Market Today
At a stroke, it's got a product authorized for a specific use in 27 countries.
Chips, Glorious Chips!
Someone's gotta make 'em, and someone's gotta buy 'em.
Why Tandem Diabetes Stock Just Jumped 22%
Tandem Diabetes stock is showing great growth -- but miserable profits.
1 Beaten-Down Stock That Could Make You Richer
Don't give up on this healthcare stock too soon.
Why Tandem Diabetes Care Stock Was Zooming Higher Today
One product in particular could juice the company's fundamentals, a pundit believes.
Stocks Inch Higher After February's US Durable Goods Orders Released
Stocks are slightly up this morning as market participants reacted to February's US Durable Goods Report.
Why Tandem Diabetes Care Stock Popped Today
Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.
2 Beaten-Down Stocks That Are Worth Buying
Don't be too quick to ignore these stocks.
Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
The market has punished them, but don't overlook these stocks.